{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:01:23Z","timestamp":1790438483805,"version":"4.1.0"},"reference-count":42,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Quinuclidine derivatives are potent bioactive compounds investigated as cholinesterase inhibitors with potential intravenous therapeutic application. However, the cytotoxic properties of some, particularly those linked to oxidative stress, pose significant safety concerns. This study aimed to evaluate if flavonoid fisetin could protect cells from such toxic effects. Erythrocytes were chosen due to high susceptibility to reactive oxygen species (ROS) and well-characterised endogenous antioxidant system, making them a sensitive and physiologically relevant model. Over 24 h, human erythrocytes were exposed to QOH-C12\u201316 or QNOH-C12\u201316 derivatives to establish their 25, 50, and 75 % inhibitory concentrations (IC\n                    <jats:sub>25<\/jats:sub>\n                    , IC\n                    <jats:sub>50<\/jats:sub>\n                    , and IC\n                    <jats:sub>75<\/jats:sub>\n                    , respectively). As the compounds with the C12 side alkyl chain showed no significant haemolytic effects, they were excluded from further experimentation. In the next steps, we assessed the protective effects of fisetin (1, 10, 100 \u03bcmol\/L) against quinuclidine-induced haemolysis over 24 h and against reactive oxygen species (ROS) generation and potential glutathione (GSH) and superoxide dismutase (SOD) depletion over 4 h. Fisetin at 10 and 100 \u03bcmol\/L significantly reduced ROS to near-control levels, restored SOD activity, and decreased haemolysis by 10\u201340 %, most effectively in cells exposed to quinuclidines at IC\n                    <jats:sub>50<\/jats:sub>\n                    . However, GSH measurements in combined treatment were not reliable, as fisetin exhibited autofluorescence, but single quinuclidine exposure showed no significant effects on GSH levels. In summary, fisetin showed a promising potential to make quinuclidine intravenous therapies safer.\n                  <\/jats:p>","DOI":"10.2478\/aiht-2026-77-4134","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:52:28Z","timestamp":1790437948000},"page":"182-189","source":"Crossref","is-referenced-by-count":0,"title":["Fisetin attenuates oxidative and haemolytic damage induced by quinuclidine derivatives in human erythrocytes"],"prefix":"10.2478","volume":"77","author":[{"given":"Lucija","family":"Marceli\u0107","sequence":"first","affiliation":[{"name":"Institute for Medical Research and Occupational Health, Division of Toxicology , Zagreb , Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Malezan","sequence":"additional","affiliation":[{"name":"Institute for Medical Research and Occupational Health, Division of Toxicology , Zagreb , Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Vukovi\u0107","sequence":"additional","affiliation":[{"name":"Institute for Medical Research and Occupational Health, Division of Toxicology , Zagreb , Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Katalini\u0107","sequence":"additional","affiliation":[{"name":"Institute for Medical Research and Occupational Health, Division of Toxicology , Zagreb , Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3937-3520","authenticated-orcid":false,"given":"Antonio","family":"Zandona","sequence":"additional","affiliation":[{"name":"Institute for Medical Research and Occupational Health, Division of Toxicology , Zagreb , Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_001","doi-asserted-by":"crossref","unstructured":"\u017dunec S, Vadlja D, Rami\u0107 A, Zandona N, Marakovi\u0107 I, Brekalo I, Primo\u017ei\u010d M, Katalini\u0107 M. Profiling novel quinuclidine-based derivatives as potential anticholinesterase drugs: enzyme inhibition and effects on cell viability. Int J Mol Sci 2024;25(1):155. doi: 10.3390\/ijms25010155","DOI":"10.3390\/ijms25010155"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_002","doi-asserted-by":"crossref","unstructured":"Mato\u0161evi\u0107 A, Radman Kastelic A, Mikeli\u0107 A, Zandona A, Katalini\u0107 M, Primo\u017ei\u010d I, Bosak A, Hrenar T. Hrenar, quinuclidine-based carbamates as potential CNS active compounds. Pharmaceutics 2021;13(3):420. doi: 10.3390\/pharmaceutics13030420","DOI":"10.3390\/pharmaceutics13030420"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_003","doi-asserted-by":"crossref","unstructured":"Cavagnero PS, S\u00e1nchez Y, Fell B, Ram\u00edrez Molina O, Gavil\u00e1n J, Polo EA, Fuentealba J, Gutierrez M, Jim\u00e9nez CA, L\u00f3pez JJ. Neuroprotective activity of 3-((6-(phenylethynyl)pyridin-3-yl)oxy)quinuclidine: A potential ligand for the treatment of Alzheimer's disease. ACS Chem Neurosci 16 2025;16:4502\u201310. doi: 10.1021\/acschemneuro.5c00527","DOI":"10.1021\/acschemneuro.5c00527"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_004","doi-asserted-by":"crossref","unstructured":"Mastnak-Sokolov P, Knez D, Meden A, Stra\u0161ek Benedik N, Ferjan\u010di\u010d Benetik S, Hrast Rambaher M, Zorman M, Nachon F, Brazzolotto X, Jardemark K, Jungholm O, Bruton J, Strandback E, Nyman T, Shahid M, Gobec S. Dual cholinergic modulation in dementia: Quinuclidine carbamates targeting butyrylcholinesterase and \u03b17 nicotinic receptor. Chem Biol Interact 2026;423:111830. doi: 10.1016\/j.cbi.2025.111830","DOI":"10.1016\/j.cbi.2025.111830"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_005","doi-asserted-by":"crossref","unstructured":"Simeon-Rudolf V, Tomi\u0107 S, Bosak A, Primo\u017ei\u010d I, Orsuli\u0107 M. Preparation of enantiomers of quinuclidin-3-ol derivatives and their interactions with human cholinesterases. Chem Biol Interact 2005;157\u2013158:420\u20131. doi: 10.1016\/j.cbi.2005.10.086","DOI":"10.1016\/j.cbi.2005.10.086"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_006","doi-asserted-by":"crossref","unstructured":"Zandona A, Katalini\u0107 M, \u0160inko G, Radman Kastelic A, Primo\u017ei\u010d I, Kovarik Z. Targeting organophosphorus compounds poisoning by novel quinuclidine-3 oximes: development of butyrylcholinesterase-based bioscavengers. Arch Toxicol 2020;94:3157\u201371. doi: 10.1007\/s00204-020-02811-5","DOI":"10.1007\/s00204-020-02811-5"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_007","doi-asserted-by":"crossref","unstructured":"Luli\u0107 AM, Marceli\u0107 L, Rami\u0107 A, Kastelic AR, Zandona A, Marakovi\u0107 N, Primo\u017ei\u010d I, Katalini\u0107 M. Cholinesterase activity modulators: Evaluation of dodecylaminoquinuclidines as inhibitors of human AChE and BChE. Chem Biol Interact 2025;417:111567. doi: 10.1016\/j.cbi.2025.111567","DOI":"10.1016\/j.cbi.2025.111567"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_008","doi-asserted-by":"crossref","unstructured":"S\u00e6b\u00f8 IP, Bj\u00f8r\u00e5s M, Franzyk H, Helgesen E, Booth JA. Optimization of the hemolysis assay for the assessment of cytotoxicity. Int J Mol Sci 2023 Feb 2;24(3):2914. doi: 10.3390\/ijms24032914","DOI":"10.3390\/ijms24032914"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_009","doi-asserted-by":"crossref","unstructured":"Bettiol A, Galora S, Argento FR, Fini E, Emmi G, Mattioli I, Bagni G, Fiorillo C, Becatti M. Erythrocyte oxidative stress and thrombosis. Expert Rev Mol Med 2022 Aug 26;24:e31. doi: 10.1017\/erm.2022.25","DOI":"10.1017\/erm.2022.25"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_010","doi-asserted-by":"crossref","unstructured":"Dimitrov JD, Roumenina LT, Perrella G, Rayes J. Basic mechanisms of hemolysis-associated thrombo-inflammation and immune dysregulation. Arterioscler Thromb Vasc Biol 2023;43:1349\u201361. doi: 10.1161\/ATVBAHA.123.318780","DOI":"10.1161\/ATVBAHA.123.318780"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_011","doi-asserted-by":"crossref","unstructured":"Oberwagner W, Sauer T, Hermann A, Prohaska R, M\u00fcllner EW, Salzer U. Drug-induced endovesiculation of erythrocytes is modulated by the dynamics in the cytoskeleton\/membrane interaction. Blood Cells Mol Dis 2017;64:15\u201322. doi: 10.1016\/j.bcmd.2017.03.004","DOI":"10.1016\/j.bcmd.2017.03.004"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_012","doi-asserted-by":"crossref","unstructured":"Verma P, Kunwar A, Arai K, Iwaoka M, Indira Priyadarsini K. Alkyl chain modulated cytotoxicity and antioxidant activity of bioinspired amphiphilic selenolanes. Toxicol Res (Camb) 2015;5:434\u201345. doi: 10.1039\/c5tx00331h","DOI":"10.1039\/C5TX00331H"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_013","doi-asserted-by":"crossref","unstructured":"Durand E, Jacob RF, Sherratt S, Lecomte J, Bar\u00e9a B, Villeneuve P, Mason RP. The nonlinear effect of alkyl chain length in the membrane interactions of phenolipids: Evidence by X-ray diffraction analysis. Eur J Lipid Sci Technol 2017;119(8):1600397. doi: 10.1002\/ejlt.201600397","DOI":"10.1002\/ejlt.201600397"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_014","doi-asserted-by":"crossref","unstructured":"Orrico F, Laurance S, Lopez AC, Lefevre SD, Thomson L, M\u00f6ller MN, Ostuni MA. Oxidative stress in healthy and pathological red blood cells. Biomolecules 2023;13(8):1262. doi: 10.3390\/biom13081262","DOI":"10.3390\/biom13081262"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_015","doi-asserted-by":"crossref","unstructured":"Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol 2003;552(Pt 2):335\u201344. doi: 10.1113\/jphysiol.2003.049478","DOI":"10.1113\/jphysiol.2003.049478"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_016","doi-asserted-by":"crossref","unstructured":"Daraghmeh DN, Karaman R. The redox process in red blood cells: Balancing oxidants and antioxidants. Antioxidants (Basel) 2024;14(1):36. doi: 10.3390\/antiox14010036","DOI":"10.3390\/antiox14010036"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_017","doi-asserted-by":"crossref","unstructured":"Liu S, Liu J, Wang Y, Deng F, Deng Z. Oxidative stress: Signaling pathways, biological functions, and disease. MedComm 2025;6(7):e70268. doi: 10.1002\/mco2.70268","DOI":"10.1002\/mco2.70268"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_018","doi-asserted-by":"crossref","unstructured":"Qasim N, Mahmood R. Diminution of oxidative damage to human erythrocytes and lymphocytes by creatine: Possible role of creatine in blood. PLoS One 2015;10(11):e0141975. doi: 10.1371\/journal.pone.0141975","DOI":"10.1371\/journal.pone.0141975"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_019","doi-asserted-by":"crossref","unstructured":"Huyut Z, Beydemir \u015e, G\u00fcl\u00e7in \u0130. Antioxidant and antiradical properties of selected flavonoids and phenolic compounds. Biochem Res Int 2017;2017:7616791. doi: 10.1155\/2017\/7616791","DOI":"10.1155\/2017\/7616791"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_020","doi-asserted-by":"crossref","unstructured":"Panche AN, Diwan AD, Chandra SR. Flavonoids: An overview. J Nutr Sci 2016 Dec 29;5:e47. doi: 10.1017\/jns.2016.41","DOI":"10.1017\/jns.2016.41"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_021","doi-asserted-by":"crossref","unstructured":"Kitagawa S, Sakamoto H, Tano H. Inhibitory effects of flavonoids on free radical-induced hemolysis and their oxidative effects on haemoglobin. Chem Pharm Bull (Tokyo) 2004;52:999\u20131001. doi: 10.1248\/cpb.52.999","DOI":"10.1248\/cpb.52.999"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_022","doi-asserted-by":"crossref","unstructured":"Li S, Wang S, Zhang L, Ka Y, Zhou M, Wang Y, Tang Z, Zhang J, Wang W, Liu W. Research progress on pharmacokinetics, anti-inflammatory and immunomodulatory effects of kaempferol. Int Immunopharmacol 2025;152:114387. doi: 10.1016\/j.intimp.2025.114387","DOI":"10.1016\/j.intimp.2025.114387"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_023","doi-asserted-by":"crossref","unstructured":"Capasso L, De Masi L, Sirignano C, Maresca V, Basile A, Nebbioso A, Rigano D, Bontempo P. Epigallocatechin gallate (EGCG): Pharmacological properties, biological activities and therapeutic potential. Molecules 2025;30(3):654. doi: 10.3390\/molecules30030654","DOI":"10.3390\/molecules30030654"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_024","doi-asserted-by":"crossref","unstructured":"Park C, Noh JS, Jung Y, Leem SH, Hyun JW, Chang YC, Kwon TK, Kim GY, Lee H, Choi YH. Fisetin attenuated oxidative stress-induced cellular damage in ARPE-19 human retinal pigment epithelial cells through Nrf2-mediated activation of heme oxygenase-1. Front Pharmacol 2022;13:927898. doi: 10.3389\/fphar.2022.927898","DOI":"10.3389\/fphar.2022.927898"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_025","doi-asserted-by":"crossref","unstructured":"Piao MJ, Kim KC, Chae S, Keum YS, Kim HS, Hyun JW. Protective effect of fisetin (3,7,3\u2032,4\u2032-tetrahydroxyflavone) against \u03b3-irradiation-induced oxidative stress and cell damage. Biomol Ther (Seoul) 2013;21:210\u20135. doi: 10.4062\/biomolther.2013.017","DOI":"10.4062\/biomolther.2013.017"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_026","doi-asserted-by":"crossref","unstructured":"Ouyang J, Zhu K, Liu Z, Huang J. Prooxidant effects of epigallocatechin-3-gallate in health benefits and potential adverse effect. Oxid Med Cell Longev 2020;2020:9723686. doi: 10.1155\/2020\/9723686","DOI":"10.1155\/2020\/9723686"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_027","doi-asserted-by":"crossref","unstructured":"Boulmokh Y, Belguidoum K, Meddour F, Amira-Guebailia H. Investigation of antioxidant activity of epigallocatechin gallate and epicatechin as compared to resveratrol and ascorbic acid: experimental and theoretical insights. Struct Chem 2021;32:1907\u201323. doi: 10.1007\/s11224-021-01763-5","DOI":"10.1007\/s11224-021-01763-5"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_028","doi-asserted-by":"crossref","unstructured":"N\u00e1jera-Maldonado JM, Salazar R, Alvarez-Fitz P, Acevedo-Quiroz M, Flores-Alfaro E, Hern\u00e1ndez-Sotelo D, Espinoza-Rojo M, Ram\u00edrez M. Phenolic compounds of therapeutic interest in neuroprotection. J Xenobiot 2024;14:227\u201346. doi: 10.3390\/jox14010014","DOI":"10.3390\/jox14010014"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_029","doi-asserted-by":"crossref","unstructured":"Yang H, Hong Y, Gong M, Cai S, Yuan Z, Feng S, Chen Q, Liu X, Mei Z. Fisetin exerts neuroprotective effects in vivo and in vitro by inhibiting ferroptosis and oxidative stress after traumatic brain injury. Front Pharmacol 2024;15:1480345. doi: 10.3389\/fphar.2024.1480345","DOI":"10.3389\/fphar.2024.1480345"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_030","doi-asserted-by":"crossref","unstructured":"Maher P. How fisetin reduces the impact of age and disease on CNS function. Front Biosci (Schol Ed) 2015;7:58\u201382. doi: 10.2741\/S425","DOI":"10.2741\/425"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_031","doi-asserted-by":"crossref","unstructured":"Cordaro M, D'Amico R, Fusco R, Peritore AF, Genovese T, Interdonato L, Franco G, Arangia A, Gugliandolo E, Crupi R, Siracusa R, Di Paola R, Cuzzocrea S, Impellizzeri D. Discovering the effects of fisetin on NF-\u03baB\/NLRP-3\/NRF-2 molecular pathways in a mouse model of vascular dementia induced by repeated bilateral carotid occlusion. Biomedicines 2022;10(6):1448. doi: 10.3390\/biomedicines10061448","DOI":"10.3390\/biomedicines10061448"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_032","doi-asserted-by":"crossref","unstructured":"\u010cali\u0107 M, Vrdoljak AL, Radi\u0107 B, Jeli\u0107 D, Jun D, Ku\u010da K, Kovarik Z. In vitro and in vivo evaluation of pyridinium oximes: Mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity. Toxicology 2006;219:85\u201396. doi: 10.1016\/j.tox.2005.11.003","DOI":"10.1016\/j.tox.2005.11.003"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_033","doi-asserted-by":"crossref","unstructured":"Zandona A, Juri\u0107 M, Jean L, Renard PY, Katalini\u0107 M. Assessment of cytotoxic properties of tetrahydroisoquinoline oximes in breast, prostate and glioblastoma cancer cells. Drug Chem Toxicol 2025;48:856\u201363. doi: 10.1080\/01480545.2025.2491534","DOI":"10.1080\/01480545.2025.2491534"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_034","doi-asserted-by":"crossref","unstructured":"Zandona A, Szecsk\u00f3 A, \u017dunec S, Novak Jovanovi\u0107 I, Bu\u0161i\u0107 V, Soka\u010d DG, Deli MA, Katalini\u0107 M, Veszelka S. Nicotinamide derivatives protect the blood-brain barrier against oxidative stress. Biomed Pharmacother 2025;186:118018. doi: 10.1016\/j.biopha.2025.118018","DOI":"10.1016\/j.biopha.2025.118018"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_035","doi-asserted-by":"crossref","unstructured":"Crn\u010devi\u0107 D, Rami\u0107 A, Kastelic AR, Od\u017eak R, Krce L, Weber I, Primo\u017ei\u010d I, \u0160prung M. Naturally derived 3-aminoquinuclidine salts as new promising therapeutic agents. Sci Rep 2024;14(1):26211. doi: 10.1038\/s41598-024-77647-5","DOI":"10.1038\/s41598-024-77647-5"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_036","doi-asserted-by":"crossref","unstructured":"Zhang H, Zheng W, Feng X, Yang F, Qin H, Wu S, Hou DX, Chen J. Nrf2\u2013ARE signaling acts as master pathway for the cellular antioxidant activity of fisetin. Molecules 2019;24(4):708. doi: 10.3390\/molecules24040708","DOI":"10.3390\/molecules24040708"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_037","doi-asserted-by":"crossref","unstructured":"Jiang L, Yanase E, Mori T, Kurata K, Toyama M, Tsuchiya A, Yamauchi K, Mitsunaga T, Iwahashi H, Takahashi J. Relationship between flavonoid structure and reactive oxygen species generation upon ultraviolet and X-ray irradiation. J Photochem Photobiol A Chem 2019;384:112044. doi: 10.1016\/j.jphotochem.2019.112044","DOI":"10.1016\/j.jphotochem.2019.112044"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_038","doi-asserted-by":"crossref","unstructured":"Speisky H, Shahidi F, Costa de Camargo A, Fuentes J. Revisiting the oxidation of flavonoids: Loss, conservation or enhancement of their antioxidant properties. Antioxidants (Basel) 2022;11(1):133. doi: 10.3390\/antiox11010133","DOI":"10.3390\/antiox11010133"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_039","doi-asserted-by":"crossref","unstructured":"M\u00f6ller MN, Orrico F, Villar SF, L\u00f3pez AC, Silva N, Donz\u00e9 M, Thomson L, Denicola A. Oxidants and antioxidants in the redox biochemistry of human red blood cells. ACS Omega 2023;8:147\u201368. doi: 10.1021\/acsomega.2c06768","DOI":"10.1021\/acsomega.2c06768"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_040","doi-asserted-by":"crossref","unstructured":"Dai F, Miao Q, Zhou B, Yang L, Liu ZL. Protective effects of flavonols and their glycosides against free radical-induced oxidative hemolysis of red blood cells. Life Sci 2006;78(21):2488\u201393. doi: 10.1016\/j.lfs.2005.10.009","DOI":"10.1016\/j.lfs.2005.10.009"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_041","doi-asserted-by":"crossref","unstructured":"An F, Wang S, Yuan D, Gong Y, Wang S. Attenuation of oxidative stress of erythrocytes by plant-derived flavonoids, orientin and luteolin. Evid Based Complement Alter nat Med 2016;2016:3401269. doi: 10.1155\/2016\/3401269","DOI":"10.1155\/2016\/3401269"},{"key":"2026092615522420805_j_aiht-2026-77-4134_ref_042","doi-asserted-by":"crossref","unstructured":"Zheng Q, Tan W, Feng X, et al. Protective effect of flavonoids from mulberry leaf on AAPH-induced oxidative damage in sheep erythrocytes. Molecules 2022;27(21):7625. doi: 10.3390\/molecules27217625","DOI":"10.3390\/molecules27217625"}],"container-title":["Archives of Industrial Hygiene and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/aiht-2026-77-4134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:52:42Z","timestamp":1790437962000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/aiht-2026-77-4134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9,25]]},"published-print":{"date-parts":[[2026,9,1]]}},"alternative-id":["10.2478\/aiht-2026-77-4134"],"URL":"https:\/\/doi.org\/10.2478\/aiht-2026-77-4134","relation":{},"ISSN":["1848-6312"],"issn-type":[{"value":"1848-6312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}